111 related articles for article (PubMed ID: 25090928)
1. Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
Aly RM; Ghazy HF
Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
[TBL] [Abstract][Full Text] [Related]
2. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.
Mu Q; Wang Y; Chen B; Qian W; Meng H; Tong H; Chen F; Ma Q; Ni W; Chen S; Jin J
Leuk Res; 2013 Aug; 37(8):922-7. PubMed ID: 23759245
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia.
Zhao HZ; Jia M; Luo ZB; Cheng YP; Xu XJ; Zhang JY; Li SS; Tang YM
Neoplasma; 2016; 63(1):150-7. PubMed ID: 26639245
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Musashi2 gene in de novo acute myeloid leukemia and its clinical implications].
Lu Y; Yu M; Mu Q; Pei R; Wang Q; Chen Z; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):713-8. PubMed ID: 25449073
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
[TBL] [Abstract][Full Text] [Related]
7. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
8. MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia.
Byers RJ; Currie T; Tholouli E; Rodig SJ; Kutok JL
Blood; 2011 Sep; 118(10):2857-67. PubMed ID: 21753187
[TBL] [Abstract][Full Text] [Related]
9. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
[TBL] [Abstract][Full Text] [Related]
11. Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
Abou Mourad YR; Bhargava R; Bruyère H; Gillian T; Barnett MJ; Forrest DL; Nevill TJ; Toze CL; Nantel SH; Shepherd JD
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):281-6. PubMed ID: 23098889
[TBL] [Abstract][Full Text] [Related]
12. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
[TBL] [Abstract][Full Text] [Related]
13. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
[TBL] [Abstract][Full Text] [Related]
14. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness.
Guillaume N; Penther D; Vaida I; Gruson B; Harrivel V; Claisse JF; Capiod JC; Lefrere JJ; Damaj G
Int J Lab Hematol; 2011 Feb; 33(1):92-6. PubMed ID: 20666852
[TBL] [Abstract][Full Text] [Related]
15. Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.
Lin X; Zou X; Wang Z; Fang Q; Chen S; Huang J; Zhe N; Yu M; Zhang Y; Wang J
Oncotarget; 2016 Aug; 7(33):53679-53701. PubMed ID: 27447561
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics and prognostic significance of AID, miR-181b, and miR-155 expression in adult patients with de novo B-cell acute lymphoblastic leukemia.
Zhou G; Cao Y; Dong W; Lin Y; Wang Q; Wu W; Hua X; Ling Y; Xie X; Hu S; Cen J; Gu W
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28140712
[TBL] [Abstract][Full Text] [Related]
17. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.
McClellan JS; Dove C; Gentles AJ; Ryan CE; Majeti R
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4074-9. PubMed ID: 25775523
[TBL] [Abstract][Full Text] [Related]
19. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
[TBL] [Abstract][Full Text] [Related]
20. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
